Cart
sales@molnova.com
SB408124
CAS No. 288150-92-5
SB408124( —— )
Catalog No. M17465 CAS No. 288150-92-5
SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 73 | Get Quote |
|
| 25MG | 162 | Get Quote |
|
| 50MG | 291 | Get Quote |
|
| 100MG | 431 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSB408124
-
NoteResearch use only, not for human use.
-
Brief DescriptionSB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
-
DescriptionSB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
-
In Vitro——
-
In VivoSB-408124 (30 μg/10 μl; i.c.v.; male Wistar rats) decreases Orexin-A induced water intake in Wistar rats.
-
Synonyms——
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorOX1 (membrane)| OX1 (whole cell)
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number288150-92-5
-
Formula Weight356.37
-
Molecular FormulaC19H18F2N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO : 50 mg/mL 140.30 mM; H2O : < 0.1 mg/mL
-
SMILESCN(C)C1=CC=C(NC(=O)NC2=CC(C)=NC3=C(F)C=C(F)C=C23)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Langmead CJ, et al, Br J Pharmacol, 2004, 141(2) , 340-346.
molnova catalog
related products
-
ZINC72115182
N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide is a novel selective inhibitor.
-
RMC-0331
RMC-0331 (RM-023) is an orally available and potent SOS1 inhibitor with potential anticancer activity, blocking RAS activation by disrupting RAS-SOS1 interactions.
-
Vemurafenib
Vemurafenib (PLX-4032;RG7204;RO5185426) is a potent, selective B-RAF V600E inhibitor with IC50 of 30 nM.
